ArticleJournal of ovarian research2011

Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin.

Cheryl A Sherman-Baust et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.